The Risk of Systemic Lupus Erythematosus Associated With Vaccines An International Case-Control Study

被引:29
作者
Grimaldi-Bensouda, Lamiae [1 ,2 ]
Le Guern, Veronique [3 ,4 ]
Kone-Paut, Isabelle [5 ]
Aubrun, Elodie [1 ]
Fain, Olivier [6 ,7 ]
Ruel, Michel [8 ]
Machet, Laurent [9 ,10 ]
Viallard, Jean-Francois [11 ,12 ]
Magy-Bertrand, Nadine [13 ]
Daugas, Eric [14 ]
Rossignol, Michel [15 ,16 ]
Abenhaim, Lucien [17 ,18 ]
Costedoat-Chalumeau, Nathalie [19 ,20 ]
机构
[1] LA SER, F-75014 Paris, France
[2] Conservatoire Natl Arts & Metiers, Paris, France
[3] Univ Paris 05, Paris, France
[4] Ctr Hosp Univ CHU Cochin, AP HP, Paris, France
[5] CHU Le Kremlin Bicetre, AP HP, Le Kremlin Bicetre, France
[6] Univ Paris Nord, Sorbonne Paris Cite, Paris, France
[7] CHU Jean Verdier, AP HP, Bondy, France
[8] Hop Max Fourestier, Nanterre, France
[9] Univ Tours, INSERM, CNRS, U930,ERL 3106, Tours, France
[10] Ctr Hosp Reg Univ Tours, Tours, France
[11] Hop Haut Leveque, Bordeaux, France
[12] Univ Bordeaux, Bordeaux, France
[13] CHU Jean Minjoz, Besancon, France
[14] CHU Bichat, AP HP, Paris, France
[15] McGill Univ, Montreal, PQ, Canada
[16] LA SER Ctr Risk Res, Montreal, PQ, Canada
[17] LA SER Europe Ltd, London, England
[18] London Sch Hyg & Trop Med, London WC1, England
[19] Univ Paris 06, Paris, France
[20] CHU Pitie Salpetriere, AP HP, Paris, France
关键词
HUMAN-PAPILLOMAVIRUS VACCINE; PATIENTS SELF-REPORT; HEPATITIS-B-VACCINE; ALCOHOL-CONSUMPTION; INFLUENZA VACCINATION; RHEUMATIC-DISEASES; CIGARETTE-SMOKING; EMERGING CONCEPTS; LIFE EXPECTANCY; SAFETY;
D O I
10.1002/art.38429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Studies have suggested that systemic lupus erythematosus (SLE) may be triggered by vaccinations. We undertook this study to investigate the relationship between vaccination and onset of SLE. Methods. This international case-control study was conducted between April 2008 and June 2012 in 36 specialist referral centers (34 in France and 2 in Quebec, Canada) and recruited patients <= 60 years old recently diagnosed as having either definite SLE (meeting >= 4 American College of Rheumatology [ACR] criteria including at least 1 immunologic criterion) or probable SLE (meeting 3 ACR criteria including at least 1 immunologic criterion). Controls were recruited from general practice settings through a closely monitored protocol and matched to patients by age, sex, region of residence, and date of recruitment. Vaccinations and other potential risk factors for SLE were assessed using a standardized telephone interview. We compared proportions of patients and controls who were vaccinated 12 and 24 months before the index date (date of first clinical symptom presented by the patient) using odds ratios (ORs) from conditional logistic regression. Results. We assessed 105 patients (89 with definite SLE and 16 with probable SLE) and 712 controls. Twenty-two of the 105 patients (21.0%) and 181 of the 712 controls (25.4%) had received at least 1 vaccination within 24 months before the index date (adjusted OR 0.9 [95% confidence interval 0.5-1.5]). The proportions of patients and controls vaccinated within the previous 12 months were also similar. Conclusion. Our study showed no association between exposure to vaccination and risk of developing SLE.
引用
收藏
页码:1559 / 1567
页数:9
相关论文
共 40 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   Influenza vaccination of patients with systemic lupus erythematosus: Safety and immunogenecity issues [J].
Abu-Shakra, Mahmoud ;
Press, Joseph ;
Buskila, Dan ;
Sukenik, Shaul .
AUTOIMMUNITY REVIEWS, 2007, 6 (08) :543-546
[3]   Ten cases of systemic lupus erythematosus related to hepatitis B vaccine [J].
Agmon-Levin, N. ;
Zafrir, Y. ;
Paz, Z. ;
Shilton, T. ;
Zandman-Goddard, G. ;
Shoenfeld, Y. .
LUPUS, 2009, 18 (13) :1192-1197
[4]   Vaccination and systemic lupus erythematosus: the bidirectional dilemmas [J].
Aron-Maor, A ;
Shoenfeld, Y .
LUPUS, 2001, 10 (03) :237-240
[5]  
Battafarano DF, 1998, ARTHRITIS RHEUM, V41, P1828, DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.3.CO
[6]  
2-K
[7]   Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden [J].
Bengtsson, AA ;
Rylander, L ;
Hagmar, L ;
Nived, O ;
Sturfelt, G .
RHEUMATOLOGY, 2002, 41 (05) :563-571
[8]   Association of Cigarette Smoking but Not Alcohol Consumption With Cutaneous Lupus Erythematosus [J].
Boeckler, Peggy ;
Cosnes, Anne ;
Frances, Camille ;
Hedelin, Guy ;
Lipsker, Dan .
ARCHIVES OF DERMATOLOGY, 2009, 145 (09) :1012-1016
[9]   SYSTEMIC LUPUS-ERYTHEMATOSUS - EMERGING CONCEPTS .2. DERMATOLOGICAL AND JOINT DISEASE, THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME, PREGNANCY AND HORMONAL-THERAPY, MORBIDITY AND MORTALITY, AND PATHOGENESIS [J].
BOUMPAS, DT ;
FESSLER, BJ ;
AUSTIN, HA ;
BALOW, JE ;
KLIPPEL, JH ;
LOCKSHIN, MD .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :42-53
[10]   SYSTEMIC LUPUS-ERYTHEMATOSUS - EMERGING CONCEPTS .1. RENAL, NEUROPSYCHIATRIC, CARDIOVASCULAR, PULMONARY, AND HEMATOLOGIC DISEASE [J].
BOUMPAS, DT ;
AUSTIN, HA ;
FESSLER, BJ ;
BALOW, JE ;
KLIPPEL, JH ;
LOCKSHIN, MD .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (12) :940-950